Navigation Links
Tamoxifen Helps Treat Bipolar Disorder
Date:9/12/2007

Discovery may lead to new drug to treat manic phase of the illness, study says

WEDNESDAY, Sept. 12 (HealthDay News) -- The breast cancer drug tamoxifen helps control the manic phase of bipolar disorder, and works faster than many standard medications used to treat the chronic mental illness, a new study has found.

"One of the problems with existing treatments for bipolar disorder is they seem to have this long period before they start to work," explained Dr. Husseini K. Manji, senior study author and director of the U.S. National Institute of Mental Health's mood and anxiety disorders program.

Current treatments sometimes take weeks to become effective, Manji said. "And that obviously creates a huge problem," he said. When patients are in the manic phase, particularly, not getting relief fast enough from medication may mean they need to be hospitalized, he noted.

For the study, Manji and his colleagues gave eight patients experiencing a manic episode tamoxifen, while another eight received a placebo; no one knew which drug they were getting. After three weeks, 63 percent of those on tamoxifen had reduced symptoms of mania, compared to just 13 percent of those on a placebo. The tamoxifen group responded by the fifth day of treatment.

The study results are published online in the September issue of Bipolar Disorders.

Manji and his colleagues decided to study tamoxifen because they knew that standard medications used to treat mania are known to lower the activity of an enzyme called protein kinase C, or PKC, that regulates activities in brain cells. This enzyme is believed to become overactive when bipolar disorder patients experience a manic episode.

Tamoxifen also blocks PKC, but does it more directly than some bipolar drugs, according to the researchers.

Manji and his team made the discovery after years of searching for the correct cellular target to treat bipolar diso
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Letrozole Beats Tamoxifen in Breast Cancer Therapy
2. Tamoxifen does not adversely affect the brain
3. Tamoxifen reduces breast cancer risk
4. Tamoxifen reduces breast cancer risk
5. Aromatase Inhibitors drug Femara after Tamoxifen therapy protects from breast cancer recurrence
6. Tamoxifen Ineffective In Presence Of Genetic Variation in Breast Cancer
7. New Drug More Effective than Tamoxifen in Preventing Breast Cancer Relapse
8. Raloxifene Better Than Tamoxifen For Breast Cancer
9. Aromatase Inhibitors Better Than Tamoxifen For Treating Receptor-Positive Early Breast Cancer
10. Study Identifies Mechanism Which May Help Tamoxifen Work Better
11. Tamoxifen Discontinuation Rates Surprisingly High
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Jose, California (PRWEB) July 24, 2014 ... Molecular diagnosis represents a rapidly expanding sector in ... probes, biochips, specimen collection devices, new detection technologies, ... high on sensitivity, versatility, and speed. In addition ... embraced for its benefits in patient stratification, drug ...
(Date:7/24/2014)... 24, 2014 Representatives from the internationally ... hand to provide educational and support resources at the ... week in Colorado Springs. , The Annual Meeting brings ... most renowned neurointerventional research centers in the ... together (with or at) symposiums, physician meetings, exhibit hall ...
(Date:7/24/2014)... 2014 “To care for him who shall ... orphan.” The inspired quote is attributed to Abraham Lincoln. It ... Affairs (VA). And yet the reality of Lincoln’s words, and ... for their service in times of conflict, leaves much to ... veterans locked in a battle they never expected to wage: ...
(Date:7/24/2014)... CA (PRWEB) July 24, 2014 The Republic ... unveil a new CARDAMOM CRÈME BRÛLÉE TEA to celebrate “The ... Spielberg, Oprah Winfrey and Juliet Blake. A hundred-foot journey begins ... and cross over into a new realm that is far ... however small in physical distance that materially changes the course ...
(Date:7/24/2014)... Crawford Technologies today announced the ... with AIIM, focusing on global trends in high-volume ... the survey indicated that even though organizations stated ... customer service, legal and regulatory compliance and historical ... exact facsimiles of these documents. , The survey ...
Breaking Medicine News(10 mins):Health News:Increasing Molecular Level Understanding of Disease State & Metabolism Drives the Molecular Diagnostics Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Increasing Molecular Level Understanding of Disease State & Metabolism Drives the Molecular Diagnostics Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Increasing Molecular Level Understanding of Disease State & Metabolism Drives the Molecular Diagnostics Market, According to New Report by Global Industry Analysts, Inc. 4Health News:Brain Aneurysm Foundation Provides Key Support to NeuroIntervential Physicians 2Health News:LawyersandSettlements.com Interviews Veterans Benefits Attorney Shanin Specter about Recent VA Hospital Reports 2Health News:LawyersandSettlements.com Interviews Veterans Benefits Attorney Shanin Specter about Recent VA Hospital Reports 3Health News:LawyersandSettlements.com Interviews Veterans Benefits Attorney Shanin Specter about Recent VA Hospital Reports 4Health News:LawyersandSettlements.com Interviews Veterans Benefits Attorney Shanin Specter about Recent VA Hospital Reports 5Health News:The Republic of Tea Unveils New Tea Inspired by “The Hundred-Foot Journey” 2Health News:The Republic of Tea Unveils New Tea Inspired by “The Hundred-Foot Journey” 3Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 2Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 3Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 4
... as "lazy eye," is a major cause of vision problems ... aged 20 to 70 in developed countries. In amblyopia the ... loses visual power as a result. When the condition is ... of children achieve 20/30 vision or better, the Amblyopia Treatment ...
... with rufinamide results in a significant reduction in seizure ... seizures (POS). Details of this study are now available ... Wiley-Blackwell on behalf of the International League Against Epilepsy. ... worldwide population according to the Centers for Disease Control ...
... study, derived from novel sleep research conducted by University of ... secret to a long life may come with just enough ... enough; eight hours is probably too much. A team ... of psychiatry at UC San Diego School of Medicine, revisited ...
... and MIT have reported a new way to biosynthesize ... an engineered strain of E. coli bacteria. ... to achieving cost-effective, large-scale production of Taxol and the ... work is reported in the October 1, 2010, issue ...
... neurologic disorders such as stroke, headache, Parkinson,s disease, epilepsy and ... journal Neurologic Clinics . Guest editor is Dr. ... University Chicago Stritch School of Medicine. "Great therapeutic strides ... decades," Biller wrote in the preface to the November 2010 ...
... MD, chief of Infectious Diseases at Nationwide Children,s Hospital, ... in a five-year, $3.4 million grant from the Eunice ... Development. Dr. Ramilo and a team of more than ... use of novel technologies for distinguishing between bacterial and ...
Cached Medicine News:Health News:Is photoscreening the best way to catch 'lazy eye'? 2Health News:Adjunctive rufinamide reduces refractory partial-onset seizures 2Health News:Women's study finds longevity means getting just enough sleep 2Health News:Researchers advance biosynthesis of potent anti-cancer drug Taxol 2Health News:NCH investigators receive grant to distinguish bacterial infections from viral infections in infants 2
(Date:7/23/2014)... Top Staten Island Pediatrician Dr. Michael Gabriel ... discusses tips for parents about pool safety for children. ... to US News article, "Drowning is the leading ... 1 to 4, and can occur in as little as ... article says that watching a child in the water every ...
(Date:7/23/2014)... , July 23, 2014  Mezzion Pharma Co. ... to evaluate the use of udenafil to treat adolescents ... ventricle heart defects. The clinical program will follow protocols ... the Pediatric Heart Network (PHN), a multi-center clinical research ... Institute (NHLBI) of the National Institutes of Health (NIH). ...
(Date:7/23/2014)... July 23, 2014  Nearly 8,000 attendees will converge ... Health,s annual Retail Business Conference (RBC), taking place July ... This year,s event encourages pharmacists to "Lead Change" in ... and for their future. "RBC ... network with their peers and learn new ways they ...
Breaking Medicine Technology:Premier Staten Island Pediatrician Dr. Michael Gabriel Comments On Article Discussing Pool Safety Tips for Parents 2Mezzion Pharma Initiates Clinical Development Program To Evaluate Udenafil In Adolescents With Single Ventricle Heart Defects 2Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 2Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 3Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 4Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 5Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 6
... , NASHVILLE, Tenn. , ... provider of medical cost management services, today commended two new ... scans and other diagnostic imaging tests. , "When used ... said Gregg Allen, M.D., chief medical officer of MedSolutions. "However, ...
... , FORT WORTH, ... Board: WNDM) a rapidly growing provider of specialty medical products, ... toward productization of its patented orthopedic bone void fillers. ... 2010, to the bio-products market, estimated to be a multi-billion ...
Cached Medicine Technology:MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 2MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 3Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 2Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 3
... Combines BchiVac V-500 and water-cooled secondary condenser ... is a powerful PTFE membrane vacuum pump ... Applications Ideally suited for use ... Laboratory vacuum source for instruments including ...
... UVS400 is a multi-tasking vacuum source and ... refrigerated vapor trap and a maintenance-free, oil-free ... The easy-to-use, wide-mouth glass condensation flask collects ... for easy disposal. The UVS400 provides an ...
Universal vacuum pump (capacity 34 L/min, 8 mbar vacuum abs.)...
... with Vacuum Controller V-800 Efficiently controls vacuum ... on and off as needed to maintain preset vacuum ... is a powerful PTFE membrane vacuum pump designed to ... suited for use with up to two rotary evaporators ...
Medicine Products: